Torrent Pharmaceuticals stock reports 54.6 percent sales growth
Published on 09/25/2026 at 11:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Torrent Pharmaceuticals stock traded at INR 4,955 on NSE on September 25, 2026, up 0.54 percent, while the latest quarter showed 54.6 percent growth in quarterly net sales. For Q1 FY27, DSIJ reports that the combined business delivered revenue of INR 48.35 billion and EBITDA of INR 16.64 billion.
JB Pharma lifts quarterly scale
The Q1 FY27 figures show the effect of Torrent Pharmaceuticals' integration of JB Pharma. Consolidated EBITDA carried a 33.8 percent margin, while quarterly EBITDA increased 61.2 percent year over year, according to DSIJ.
The underlying business also contributed to the result. Base-business revenue excluding JB Pharma was INR 37.20 billion in Q1 FY27, up 17 percent year over year, while base-business EBITDA reached INR 12.40 billion, up 20 percent, the report states.
Margins show the integration effect
JB Pharma generated an EBITDA margin of 35.3 percent in Q1 FY27, compared with 28.8 percent a year earlier. The 6.5 percentage-point improvement gives the acquisition a measurable operating contribution beyond the reported sales increase, based on the figures published by DSIJ.
Geographic growth was uneven but positive across the main markets. Q1 FY27 growth reached 19 percent in India, 27 percent in Brazil, 36 percent in the United States and 3 percent in Germany.
Stock remains below yearly high
At INR 4,955 on September 25, 2026, the stock stood 5.62 percent below its 52-week high of INR 5,250. The distance leaves the market price below its yearly peak even as the company reports stronger consolidated scale.
NSE valuation stays substantial
Torrent Pharmaceuticals had a market capitalization of INR 1,884,722,726,480 on September 25, 2026. For investors, the key calculation is the combination of 54.6 percent quarterly sales growth and a 33.8 percent EBITDA margin after the JB Pharma integration.
Torrent Pharmaceuticals market profile
- Company: Torrent Pharmaceuticals Limited
- Ticker: TORNTPHARM
- Trading venue: NSE
- Price as of September 25, 2026: INR 4,955
- Market capitalization: INR 1,884,722,726,480 as of September 25, 2026
- 52-week range: INR 3,480.60-5,250
- Sector / Industry: Healthcare / Drug Manufacturers - Specialty and Generic
